메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
박형득 (메드트로닉코리아) 강영현 (메드트로닉코리아) 김주연 (성균관대학교)
저널정보
한국보건의료기술평가학회 보건의료기술평가 보건의료기술평가 제11권 제1호
발행연도
2023.6
수록면
1 - 8 (8page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Objectives: Sudden cardiac death is a condition in which a person experiences malignant ventricular arrhythmias, resulting in spontaneous death, usually within an hour of the onset of symptoms. Implantable cardioverter defibrillators (ICDs) are an effective treatment for the prevention of sudden cardiac death, but the clinical benefits of ICD use are often offset by a variety of adverse events associated with the transvenous leads, which are implanted inside cardiac chamber through the venous system. Recently, ICDs with electrodes inserted into extravascular (EV) sites, such as the substernal or parasternal area, have been developed. This study was conducted to compare the clinical safety and effectiveness of EV-ICD and subcutaneous ICD (S-ICD), using a matching-adjusted indirect comparison approach. Methods: The analysis included the EV-ICD Pivotal study (n=316) and the S-ICD System investigational device exemption (IDE) study (n=321). We analyzed the following outcome variables: major adverse events up to 6 months and defibrillation test success rates. We conducted an unanchored matching-adjusted indirect comparison analysis to estimate the relative treatment effect. Comparison of the incidence of major adverse events was performed by Kaplan- Meier survival function Cox proportional hazards model. For the comparison of defibrillation test success rates, odds ratios (ORs) between the treatments were estimated using logistic regression. Results: Baseline characteristics between treatment groups were adjusted to be equal through matching- adjusted indirect comparison approach. Kaplan-Meier survival analysis of the occurrence of major adverse events showed an unadjusted hazard ratio (HR) of 0.86 (95% confidence interval [CI]: 0.49–1.50, p=0.59), and an adjusted HR of 0.92 (95% CI: 0.58–1.44, p=0.49). The analysis of defibrillation test success rates showed an unadjusted OR of 0.93 (95% CI: 0.47–1.83, p=0.83), an adjusted OR estimated of 0.86 (95% CI: 0.50–1.48, p=0.52). Conclusion: A major adverse event rates and defibrillation test success rates between EV-ICD and S-ICD were analyzed using the matching-adjusted indirect comparison method and found no significant differences between the two treatments.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

최근 본 자료

전체보기

댓글(0)

0